Evidence map›Paper›PMID 41875623›Full record

ArticleThe Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Risk factors for post-COVID-19 condition: A case-control study in municipalities of Paraíba and Rio de Janeiro, Brazil.

Clarice Monteiro Vianna, Alexandre Medeiros de Figueiredo, Luiz Antonio Bastos Camacho, Celia Menezes Cruz Marques, Janaina Reis Xavier, Vitor Cardoso da Gama, Geovanna de Lima Cunha Pizzini, Renan Marinho Braga, Ewerton Alves Portela Dos Santos, Maria de Lourdes de Sousa Maia

Abstract readMulticenter Study
In one paragraph

Article in The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Clarice Monteiro ViannaInstituto de Tecnologia em Imunobiológicos Bio-Manguinhos (FIOCRUZ), Rio de Janeiro, RJ, Brazil. Electronic address: clarice.vianna@bio.fiocruz.br.
Alexandre Medeiros de FigueiredoUniversidade Federal da Paraíba, Departamento de Promoção da Saúde, João Pessoa, PB, Brazil.
Luiz Antonio Bastos CamachoEscola Nacional de Saúde Pública (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Celia Menezes Cruz MarquesInstituto de Tecnologia em Imunobiológicos Bio-Manguinhos (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Janaina Reis XavierInstituto de Tecnologia em Imunobiológicos Bio-Manguinhos (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Vitor Cardoso da GamaInstituto de Tecnologia em Imunobiológicos Bio-Manguinhos (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Geovanna de Lima Cunha PizziniInstituto de Tecnologia em Imunobiológicos Bio-Manguinhos (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Renan Marinho BragaInstituto de Tecnologia em Imunobiológicos Bio-Manguinhos (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Ewerton Alves Portela Dos SantosInstituto de Tecnologia em Imunobiológicos Bio-Manguinhos (FIOCRUZ), Rio de Janeiro, RJ, Brazil.
Maria de Lourdes de Sousa MaiaInstituto de Tecnologia em Imunobiológicos Bio-Manguinhos (FIOCRUZ), Rio de Janeiro, RJ, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPost-COVID-19 condition, refers to one or multiple symptoms that continue for several weeks or months following the COVID-19 infection. This study aims to assess the factors associated with post-COVID-19 condition in the Brazilians regions of Paraiba and Rio de Janeiro. Understanding this factor is crucial to public policies and improving care for high-risk individuals.

methodsThis is a multicenter, retrospective case-control study. Cases were classified as individuals experiencing persistent symptoms for over 12-weeks following a confirmed COVID-19 diagnosis, whereas controls were those who recovered. Data on sociodemographic characteristics, medical history, lifestyle factors, and vaccination status were gathered, and logistic regression was used to analyze the relationship between these variables and the onset of post-COVID-19 condition.

resultsOf the 1.350 participants, 734 were cases and 616 were controls, with a 54% frequency of post-COVID-19 condition. The study found significant associations between the syndrome and female sex (OR = 2.09; 95% CI 1.6‒2.74), middle age (OR = 2.03; 95% CI 1.31‒3.15 for 40- to 60-years) and over 60 (OR=1.84; 95% CI 1.06‒3.2), white people (OR = 1.41; 95% CI 1.07‒1.86), hypercholesterolemia (OR = 1.66; 95% CI 1.18‒2.32), chronic lung diseases (OR = 5.60; 95% CI 1.18‒26.65), mental illness such as anxiety and panic disorder (OR = 2.52; 95% CI 1.64‒3.87), family history of long COVID syndrome (OR = 2.07; 95% CI 1.45‒2.97), hospitalization (OR = 5.89; 95% CI 3.92‒8.86) and good pre-COVID health perception (OR = 0.69; 95% CI 0.53‒0.9).

conclusionsThe findings reinforce the importance of identifying groups more frequently affected by post-COVID-19 condition and supporting follow-up strategies aimed at mitigating its impact on individuals and health services.

Indexed as

COVID-19Post-Acute COVID-19 SyndromeAdultAgedBrazilCase-Control StudiesFemaleHumansMaleMiddle AgedPandemicsRetrospective StudiesRisk FactorsSARS-CoV-2Socioeconomic FactorsAssociated factorsCase-control studyLong COVIDPost-COVID-19 condition

Identifiers

PMID41875623
PMCPMC13049935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.